The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates
Abstract
The emergence of multidrug‐resistant bacteria has placed a strain on health care systems and highlighted the need for new classes of antibiotics. Bacterial lipopeptides are secondary metabolites, generally produced by nonribosomal peptide synthetases that often exhibit broad‐spectrum antimicrobial activity. Only two new structural types of antibiotics have entered the market in the last 40 years, linezolid and the bacterial lipopeptide daptomycin. A wide variety of bacteria produce lipopeptides, however Bacillus and Paenibacillus spp. in particular have yielded several potent antimicrobial lipopeptides. Many of the lipopeptides produced by these bacteria have been known for decades and represent a potential gold mine of antibiotic candidates. This list includes the polymyxins, octapeptins, polypeptins, iturins, surfactins, fengycins, fusaricidins, and tridecaptins, as well as some novel examples, including the kurstakins. These lipopeptides have a wide variety of activities, ranging from antibacterial and antifungal, to anticancer and antiviral. This review presents a reasonably comprehensive list of each class of lipopeptide and their known homologues. Emphasis has been placed on their antimicrobial activities, as well other potential applications for this interesting class of substances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacillus lipopeptides: versatile weapons for plant disease biocontrol
Ongena, M., & Jacques, P. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.009 · Cited by 2,418
Humans as the World's Greatest Evolutionary Force
Palumbi, S. R. (2001) · Science · doi:10.1126/science.293.5536.1786 · Cited by 1,290
Biosynthesis of Nonribosomal Peptides
Finking, R., & Marahiel, M. A. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123615 · Cited by 888
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Antibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
Koumoutsi, A., Chen, X.-H., Henne, A., Liesegang, H., Hitzeroth, G., Franke, P., Vater, J., & Borriss, R. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.1084-1096.2004 · Cited by 632
de Kraker, M. E. A., Davey, P. G., Grundmann, H., & on behalf of the BURDEN study group (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001104 · Cited by 599
Fengycin - A novel antifungal lipopeptide antibiotic produced by Bacillus subtilis F-29-3.
VANITTANAKOM, N., LOEFFLER, W., KOCH, U., & JUNG, G. (1986) · The Journal of Antibiotics · doi:10.7164/antibiotics.39.888 · Cited by 557
Production of iturin A by Bacillus amyloliquefaciens suppressing Rhizoctonia solani
Yu, G. Y., Sinclair, J. B., Hartman, G. L., & Bertagnolli, B. L. (2002) · Soil Biology and Biochemistry · doi:10.1016/s0038-0717(02)00027-5 · Cited by 418
Leclère, V., Béchet, M., Adam, A., Guez, J.-S., Wathelet, B., Ongena, M., Thonart, P., Gancel, F., Chollet-Imbert, M., & Jacques, P. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.8.4577-4584.2005 · Cited by 378
Kim, P. I., Ryu, J., Kim, Y. H., & Chi, Y.-T. (2010) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.0905.05007 · Cited by 377
Mechanism of Inactivation of Enveloped Viruses by the Biosurfactant Surfactin fromBacillus subtilis
Vollenbroich, D., Özel, M., Vater, J., Kamp, R. M., & Pauli, G. (1997) · Biologicals · doi:10.1006/biol.1997.0099 · Cited by 363
Society's failure to protect a precious resource: antibiotics
Carlet, J., Collignon, P., Goldmann, D., Goossens, H., Gyssens, I. C., Harbarth, S., Jarlier, V., Levy, S. B., N'Doye, B., Pittet, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60401-7 · Cited by 322
Bacillomycin D: an iturin with antifungal activity against Aspergillus flavus
Moyne, A.-L., Shelby, R., Cleveland, T. E., & Tuzun, S. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2001.01290.x · Cited by 299
Bonmatin, J.-M., Laprevote, O., & Peypoux, F. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620703106298716 · Cited by 288
Review of surfactin chemical properties and the potential biomedical applications
Seydlová, G., & Svobodová, J. (2008) · Open Medicine · doi:10.2478/s11536-008-0002-5 · Cited by 286
Effect of Fengycin, a Lipopeptide Produced by Bacillus subtilis, on Model Biomembranes
Deleu, M., Paquot, M., & Nylander, T. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.114090 · Cited by 263
Vollenbroich, D., Pauli, G., Ozel, M., & Vater, J. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.1.44-49.1997 · Cited by 259
Antiviral and Hemolytic Activities of Surfactin Isoforms and Their Methyl Ester Derivatives.
KRACHT, M., ROKOS, H., ÖZEL, M., KOWALL, M., PAULI, G., & VATER, J. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.613 · Cited by 237
Separation and Characterization of Surfactin Isoforms Produced byBacillus subtilisOKB 105
Kowall, M., Vater, J., Kluge, B., Stein, T., Franke, P., & Ziessow, D. (1998) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1998.5558 · Cited by 219
Detergent-Like Action of the Antibiotic Peptide Surfactin on Lipid Membranes
Heerklotz, H., & Seelig, J. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75808-0 · Cited by 211
Leakage and lysis of lipid membranes induced by the lipopeptide surfactin
Heerklotz, H., & Seelig, J. (2007) · European Biophysics Journal · doi:10.1007/s00249-006-0091-5 · Cited by 205
Structure of iturine A, a peptidolipid antibiotic from Bacillus subtilis
Peypoux, F., Guinand, M., Michel, G., Delcambe, L., Das, B. C., & Lederer, E. (1978) · Biochemistry · doi:10.1021/bi00612a018 · Cited by 195
KAJIMURA, Y., & KANEDA, M. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.129 · Cited by 182
Deleu, M., Paquot, M., & Nylander, T. (2005) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.09.036 · Cited by 182
Kim, S.-Y., Kim, J. Y., Kim, S.-H., Bae, H. J., Yi, H., Yoon, S. H., Koo, B. S., Kwon, M., Cho, J. Y., Lee, C.-E., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.059 · Cited by 181
Ramarathnam, R., Bo, S., Chen, Y., Fernando, W. G. D., Xuewen, G., & de Kievit, T. (2007) · Canadian Journal of Microbiology · doi:10.1139/w07-049 · Cited by 176
(2010) · University of Zagreb University Computing Centre (SRCE) · Cited by 174
Kurstakins: A New Class of Lipopeptides Isolated from Bacillus thuringiensis
Hathout, Y., Ho, Y.-P., Ryzhov, V., Demirev, P., & Fenselau, C. (2000) · Journal of Natural Products · doi:10.1021/np000169q · Cited by 171
Lichenysin: A More Efficient Cation Chelator Than Surfactin
Grangemard, I., Wallach, J., Maget‐Dana, R., & PEYPOUX, F. (2001) · Applied Biochemistry and Biotechnology · doi:10.1385/abab:90:3:199 · Cited by 170
Hofemeister, J., Conrad, B., Adler, B., Hofemeister, B., Feesche, J., Kucheryava, N., Steinborn, G., Franke, P., Grammel, N., Zwintscher, A., et al. (2004) · Molecular Genetics and Genomics · doi:10.1007/s00438-004-1056-y · Cited by 164
NARUSE, N., TENMYO, O., KOBARU, S., KAMEI, H., MIYAKI, T., KONISHI, M., & OKI, T. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.267 · Cited by 159
Further aspects on the hemolytic activity of the antibiotic lipopeptide iturin A
Aranda, F. J., Teruel, J. A., & Ortiz, A. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.05.003 · Cited by 158
Dehghan-Noude, G., Housaindokht, M. R., & Bazzaz, B. S. F. (2005) · PubMed · Cited by 153
Kameda, Y., OUHIRA, S., Matsui, K., Kanatomo, S., Hase, T., & ATSUSAKA, T. (1974) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.22.938 · Cited by 142
Hemolytic activity of new linear surfactin analogs in relation to their physico-chemical properties
Dufour, S., Deleu, M., Nott, K., Wathelet, B., Thonart, P., & Paquot, M. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.06.015 · Cited by 142
Lipopeptides as anti-infectives: a practical perspective
Pirri, G., Giuliani, A., Nicoletto, S. F., Pizzuto, L., & Rinaldi, A. C. (2009) · Open Life Sciences · doi:10.2478/s11535-009-0031-3 · Cited by 139
Determination of Fatty Acid in Surfactin and Elucidation of the Total Structure of Surfactin
Kakinuma, A., Sugino, H., ISONO, M., Tamura, G., & Arima, Κ. (1969) · Agricultural and Biological Chemistry · doi:10.1080/00021369.1969.10859409 · Cited by 138
Pathak, K. V., Keharia, H., Gupta, K., Thakur, S. S., & Balaram, P. (2012) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-012-0437-4 · Cited by 134
Sabaté, D. C., & Audisio, M. C. (2012) · Microbiological Research · doi:10.1016/j.micres.2012.11.004 · Cited by 128
Kajimura, Y., & Kaneda, M. (1997) · The Journal of Antibiotics · doi:10.7164/antibiotics.50.220 · Cited by 126
Cho, S., Lee, S. K., Cha, B. J., Kim, Y. H., & Shin, K.-S. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00329-x · Cited by 123
Isolation and characterization of a new variant of surfactin, the [Val7]surfactin
PEYPOUX, F., Bonmatin, J., LABBÉ, H., Das, B. C., Ptak, M., & Michel, G. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16349.x · Cited by 118
A study on the interactions of surfactin with phospholipid vesicles
Grau, A., Gómez-Fernández, J. C., PEYPOUX, F., & Ortiz, A. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00039-5 · Cited by 117
Structures of bacillomycin D and bacillomycin L peptidolipid antibiotics from Bacillus subtilis.
PEYPOUX, F., Pommier, M. T., Das, B. C., Besson, F., DELCAMBE, L., & Michel, G. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1600 · Cited by 111
Qian, C., Wu, X., Teng, Y., Zhao, W., Li, O., Fang, S., Huang, Z., & Gao, H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05580-11 · Cited by 110
Ma, Z., Wang, N., Hu, J., & Wang, S. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2012.19 · Cited by 108
Halobacillin: A cytotoxic cyclic acylpeptide of the iturin class produced by a marine Bacillus
Trischman, J. A., Jensen, P. R., & Fenical, W. (1994) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)77249-2 · Cited by 108
Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells
Azad, M. A. K., Finnin, B. A., Poudyal, A., Davis, K., Li, J., Hill, P., Nation, R. L., Velkov, T., & Li, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02587-12 · Cited by 107
[Ala4]Surfactin, a Novel Isoform from Bacillus subtilis Studied by Mass and NMR Spectroscopies
PEYPOUX, F., Bonmatin, J., Labbe, H., Grangemard, I., Das, B. C., Ptak, M., Wallach, J., & Michel, G. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19998.x · Cited by 106
Structure, biosynthesis, and properties of kurstakins, nonribosomal lipopeptides from Bacillus spp.
Béchet, M., Caradec, T., Hussein, W., Abderrahmani, A., Chollet, M., Leclère, V., Dubois, T., Lereclus, D., Pupin, M., & Jacques, P. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4181-2 · Cited by 106
Revised structure of mycosubtilin, a peptidolipid antibiotic from Bacillus subtilis.
PEYPOUX, F., Pommier, M. T., Marion, D., Ptak, M., Das, B. C., & Michel, G. (1986) · The Journal of Antibiotics · doi:10.7164/antibiotics.39.636 · Cited by 105
Pore-forming properties of iturin A, a lipopeptide antibiotic
Maget‐Dana, R., Ptak, M., PEYPOUX, F., & Michel, G. (1985) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(85)90367-0 · Cited by 102
Nishikiori, T., NAGANAWA, H., MURAOKA, Y., AOYAGI, T., & UMEZAWA, H. (1986) · The Journal of Antibiotics · doi:10.7164/antibiotics.39.755 · Cited by 102
Béven, L., & Wróblewski, H. (1997) · Research in Microbiology · doi:10.1016/s0923-2508(97)87647-4 · Cited by 99
Guo, Y., Huang, E., Yuan, C., Zhang, L., & Yousef, A. E. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07782-11 · Cited by 97
Identification of amino acid substitutions in the lipopeptide surfactin using 2D NMR spectroscopy
Baumgart, F., Kluge, B., Ullrich, C., Vater, J., & Ziessow, D. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90637-m · Cited by 95
Gong, M., Wang, J.-D., Zhang, J., Yang, H., Lu, X., Pei, Y., & Cheng, J. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00157.x · Cited by 91
Bacillopeptins, New Cyclic Lipopeptide Antibiotics from Bacillus subtilis FR-2.
Kajimura, Y., Sugiyama, M., & Kaneda, M. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.1095 · Cited by 90
Phister, T. G., O’Sullivan, D. J., & McKay, L. L. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.1.631-634.2004 · Cited by 89
Eshita, S. M., Roberto, N. H., Beale, J. M., Mamiya, B. M., & Workman, R. F. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.1240 · Cited by 87
Three New Cytotoxic Cyclic Acylpeptides from Marine Bacillus sp.
Zhang, H. L., Hua, H. M., Pei, Y., & Yao, X. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.1029 · Cited by 83
Identification of antibiotics of iturin group in various strains of Bacillus subtilis.
Besson, F., PEYPOUX, F., Michel, G., & DELCAMBE, L. (1978) · The Journal of Antibiotics · doi:10.7164/antibiotics.31.284 · Cited by 82
Yakimov, M. M., Abraham, W., Meyer, H., Giuliano, L., & Golyshin, P. N. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00058-x · Cited by 81
Gavaserin and saltavalin, new peptide antibiotics produced byBacillus polymyxa
Pichard, B., Larue, J.-P., & Thouvenot, D. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07887.x · Cited by 78
Production, isolation and characterization of [Leu4]- and [Ile4]surfactins from Bacillus subtilis
Bonmatin, J., Labb�, H., Grangemard, I., Peypoux, F., Maget-Dana, R., Ptak, M., & Michel, G. (1995) · Letters in Peptide Science · doi:10.1007/bf00122922 · Cited by 78
Grangemard, I., Bonmatin, J., Bernillon, J., Das, B. C., & PEYPOUX, F. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.363 · Cited by 77
Interactions of bioactive lipopeptides, iturin A and surfactin from Bacillus subtilis
Thimon, L., PEYPOUX, F., Maget, R. D., et al. (1992) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1992.tb00218.x · Cited by 76
Yin, H., Guo, C., Wang, Y., Liu, D., Lv, Y., Lv, F., & Lu, Z. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283611395 · Cited by 75
Roy, A., Mahata, D., Paul, D., Korpole, S., Franco, O. L., & Mandal, S. M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00332 · Cited by 74
Symmank, H., Franke, P., Saenger, W., & Bernhard, F. (2002) · Protein Engineering Design and Selection · doi:10.1093/protein/15.11.913 · Cited by 74
Structure of the peptide antibiotic polypeptin
Sogn, J. A. (1976) · Journal of Medicinal Chemistry · doi:10.1021/jm00232a012 · Cited by 67
Lohans, C. T., Huang, Z., van Belkum, M. J., Giroud, M., Sit, C. S., Steels, E. M., Zheng, J., Whittal, R. M., McMullen, L. M., & Vederas, J. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3089229 · Cited by 64
Self-citationThasana, N., Prapagdee, B., Rangkadilok, N., Sallabhan, R., Aye, S. L., Ruchirawat, S., & Loprasert, S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.005 · Cited by 61
Hwang, Y., Park, B.-K., Lim, J., Kim, M.-S., Park, S., Hwang, M., & Yun, H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.031 · Cited by 61
UMEZAWA, H., AOYAGI, T., Nishikiori, T., Okuyama, A., YAMAGISHI, Y., HAMADA, M., & TAKEUCHI, T. (1986) · The Journal of Antibiotics · doi:10.7164/antibiotics.39.737 · Cited by 61
Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis
Klich, M. A., Lax, A. R., & Bland, J. M. (1991) · Mycopathologia · doi:10.1007/bf00436368 · Cited by 60
Bacillomycin F, a new antibiotic of iturin group: isolation and characterization.
MHAMMEDI, A., PEYPOUX, F., Besson, F., & Michel, G. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.306 · Cited by 60
Structure of bacillomycin F, a new peptidolipid antibiotic of the iturin group
PEYPOUX, F., Marion, D., Maget‐Dana, R., Ptak, M., Das, B. C., & Michel, G. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb09307.x · Cited by 59
Bionda, N., Stawikowski, M. J., Stawikowska, R., Čudić, M., López-Vallejo, F., Treitl, D., Medina‐Franco, J. L., & Čudić, P. (2012) · ChemMedChem · doi:10.1002/cmdc.201200016 · Cited by 58
Grangemard, I., PEYPOUX, F., Wallach, J., Das, B. C., Labbé, H., Caille, A., Genest, M., Maget‐Dana, R., Ptak, M., & Bonmatin, J. (1997) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199703)3:2<145::aid-psc96>3.0.co;2-y · Cited by 58
Iturin AL - A new long chain iturin a possessing an unusual high content of C16-.BETA.-amino acids.
Winkelmann, G., Allgaier, H., Lupp, R., & Jung, G. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.1451 · Cited by 51
Lee, S.-C., Kim, S.-H., Park, I., Chung, S.-Y., Chandra, M. S., & Yong-Lark, C. (2010) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-009-0037-8 · Cited by 48
Nasir, M. N., & Besson, F. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2012.07.091 · Cited by 47
Identification of LI-F type antibiotics and di-n-butyl phthalate produced by Paenibacillus polymyxa
Deng, Y., Lu, Z., Lü, F., Zhang, C., Wang, Y., Zhao, H., & Bie, X. (2011) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2011.02.013 · Cited by 46
NAKAJIMA, N., Chihara, S., & KOYAMA, Y. (1972) · The Journal of Antibiotics · doi:10.7164/antibiotics.25.243 · Cited by 39
EM49: A NEW POLYPEPTIDE ANTIBIOTIC ACTIVE AGAINST CELL MEMBRANES
Meyers, E., Parker, W. L., Brown, W. E., Linnett, P. E., & Strominger, J. L. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb43286.x · Cited by 37
Hosono, K., & Suzuki, H. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.674 · Cited by 37
Key Residues in Octyl‐Tridecaptin A1 Analogues Linked to Stable Secondary Structures in the Membrane
Cochrane, S. A., Findlay, B., Vederas, J. C., & Ratemi, E. (2014) · ChemBioChem · doi:10.1002/cbic.201402024 · Cited by 35
Self-citationStructure de l'iturine C de Bacillus subtilis
PEYPOUX, F., Besson, F., Michel, G., DELCAMBE, L., & Das, B. C. (1978) · Tetrahedron · doi:10.1016/0040-4020(78)80138-0 · Cited by 32
EM49, a new peptide antibiotic. IV. The structure of EM49.
Parker, W. L., & Rathnum, M. L. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.379 · Cited by 31
Polymyxins and Analogues Bind to Ribosomal RNA and Interfere with Eukaryotic Translation in Vitro
McCoy, L. S., Roberts, K. D., Nation, R. L., et al. (2013) · ChemBioChem · doi:10.1002/cbic.201300496 · Cited by 31
Jokipeptin, a new peptide antibiotic. I. Isolation, physico-chemical and biological characteristics.
Ito, M., & Koyama, Y. (1972) · PubMed · Cited by 25
JOLIPEPTIN, A NEW PEPTIDE ANTIBIOTIC
Ito, M., & KOYAMA, Y. (1972) · The Journal of Antibiotics · doi:10.7164/antibiotics.25.309 · Cited by 21
Interactions of the lipopeptide antifungal iturin A with lipids in mixed monolayers
Maget‐Dana, R., Harnois, I., & Ptak, M. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90042-4 · Cited by 21
POLYPEPTIN, AN ANTIBIOTIC FROM A MEMBER OF THE BACILLUS CIRCULANS GROUP
Howell, S. F. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56279-7 · Cited by 10
Research works printed but not linked: 63
- 10.7164/antibiotics.38.1610 · doi:10.7164/antibiotics.38.1610
- Stansly PG, 1947, Polymyxin: A new chemotherapeutic agent, Bull Johns Hopkins Hosp, 81, 43
- 10.1016/j.ab.2010.10.033 · doi:10.1016/j.ab.2010.10.033
- 10.1111/j.1749-6632.1949.tb27318.x · doi:10.1111/j.1749-6632.1949.tb27318.x
- 10.1128/AAC.00119-11 · doi:10.1128/aac.00119-11
- 10.1016/S0021-9673(00)92299-4 · doi:10.1016/s0021-9673(00)92299-4
- 10.1007/BF01901128 · doi:10.1007/bf01901128
- 10.7164/antibiotics.54.595 · doi:10.7164/antibiotics.54.595
- 10.1074/jbc.M212364200 · doi:10.1074/jbc.m212364200
- 10.7164/antibiotics.26.444 · doi:10.7164/antibiotics.26.444
- 10.7164/antibiotics.26.449 · doi:10.7164/antibiotics.26.449
- 10.7164/antibiotics.26.457 · doi:10.7164/antibiotics.26.457
- 10.1016/S0021-9673(01)97597-1 · doi:10.1016/s0021-9673(01)97597-1
- 10.7164/antibiotics.29.1339 · doi:10.7164/antibiotics.29.1339
- 10.7164/antibiotics.29.516 · doi:10.7164/antibiotics.29.516
- 10.7164/antibiotics.29.521 · doi:10.7164/antibiotics.29.521
- 10.7164/antibiotics.29.1241 · doi:10.7164/antibiotics.29.1241
- 10.7164/antibiotics.36.634 · doi:10.7164/antibiotics.36.634
- 10.1128/AAC.12.6.665 · doi:10.1128/aac.12.6.665
- 10.7164/antibiotics.32.511 · doi:10.7164/antibiotics.32.511
- 10.7164/antibiotics.33.186 · doi:10.7164/antibiotics.33.186
- Hausmann W, 1952, Polypeptin; purification, molecular weight determination, and amino acid composition, J Biol Chem, 198, 405, 10.1016/S0021-9258(18)55594-0 · doi:10.1016/s0021-9258(18)55594-0
- 10.7164/antibiotics.32.121 · doi:10.7164/antibiotics.32.121
- 10.7164/antibiotics.32.115 · doi:10.7164/antibiotics.32.115
- 10.1111/j.1574-6968.2010.02040.x · doi:10.1111/j.1574-6968.2010.02040.x
- 10.1186/1471-2180-12-197 · doi:10.1186/1471-2180-12-197
- 10.1007/s12275-011-1153-7 · doi:10.1007/s12275-011-1153-7
- 10.7164/antibiotics.37.1257 · doi:10.7164/antibiotics.37.1257
- 10.1128/JB.01506-12 · doi:10.1128/jb.01506-12
- 10.1016/0014-5793(78)80292-0 · doi:10.1016/0014-5793(78)80292-0
- 10.1016/S0038-0717(02)00027-5 · DOI · Paper page
- Tenoux I, 1993, Studies on bacillomycin D biosynthesis by Bacillus subtilis, Microbios, 74, 29
- 10.1016/0021-9797(92)90319-H · DOI
- 10.1128/AAC.01030-06 · DOI
- 10.1007/s10529-005-2515-1 · DOI
- 10.1016/j.mimet.2009.09.013 · doi:10.1016/j.mimet.2009.09.013
- 10.1021/np300574v · doi:10.1021/np300574v
- 10.1016/j.bmc.2012.04.040 · doi:10.1016/j.bmc.2012.04.040
- 10.7164/antibiotics.39.888 · DOI · Paper page
- 10.1016/j.bbamem.2011.04.008 · doi:10.1016/j.bbamem.2011.04.008
- 10.7164/antibiotics.50.529 · doi:10.7164/antibiotics.50.529
- 10.7164/antibiotics.56.716 · doi:10.7164/antibiotics.56.716
- 10.7164/antibiotics.40.1506 · doi:10.7164/antibiotics.40.1506
- 10.1139/w02-002 · doi:10.1139/w02-002
- 10.1007/s10658-009-9496-1 · doi:10.1007/s10658-009-9496-1
- 10.1007/s12600-012-0263-z · doi:10.1007/s12600-012-0263-z
- 10.1002/hlca.201000094 · doi:10.1002/hlca.201000094
- 10.7164/antibiotics.25.304 · doi:10.7164/antibiotics.25.304
- 10.7164/antibiotics.25.147 · doi:10.7164/antibiotics.25.147
- 10.7164/antibiotics.28.60 · doi:10.7164/antibiotics.28.60
- 10.7164/antibiotics.28.56 · doi:10.7164/antibiotics.28.56
- 10.7164/antibiotics.28.764 · doi:10.7164/antibiotics.28.764
- 10.7164/antibiotics.29.1281 · doi:10.7164/antibiotics.29.1281
- 10.7164/antibiotics.29.1275 · doi:10.7164/antibiotics.29.1275
- 10.7164/antibiotics.29.1268 · doi:10.7164/antibiotics.29.1268
- 10.7164/antibiotics.32.313 · doi:10.7164/antibiotics.32.313
- 10.7164/antibiotics.31.652 · doi:10.7164/antibiotics.31.652
- 10.7164/antibiotics.32.305 · doi:10.7164/antibiotics.32.305
- 10.1002/cbic.201300595 · doi:10.1002/cbic.201300595
- 10.1021/jm401779d · doi:10.1021/jm401779d
- 10.1016/j.ccc.2007.12.003 · doi:10.1016/j.ccc.2007.12.003
- 10.1007/s11274-008-9752-0 · doi:10.1007/s11274-008-9752-0
- Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard‐ninth edition and performance standards for antimicrobial susceptibility testing2013;33(1):142–143.
Cited by
Current knowledge and perspectives of Paenibacillus: a review
Grady, E. N., MacDonald, J., Liu, L., Richman, A., & Yuan, Z.-C. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0603-7 · Cited by 1,003
Biological control of plant pathogens by Bacillus species
Fira, D., Dimkić, I., Berić, T., Lozo, J., & Stanković, S. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.07.044 · Cited by 917
Pathogen elimination by probiotic Bacillus via signalling interference
Piewngam, P., Zheng, Y., Nguyen, T. H., Dickey, S. W., Joo, H.-S., Villaruz, A. E., Glose, K. A., Fisher, E. L., Hunt, R. L., Li, B., et al. (2018) · Nature · doi:10.1038/s41586-018-0616-y · Cited by 644
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Kumariya, R., Garsa, A. K., Rajput, Y. S., Sood, S. K., Akhtar, N., & Patel, S. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.01.002 · Cited by 455
Metadata
- Authors
- Cochrane, S. A., & Vederas, J. C.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2014-05-28
- Volume
- 36
- Issue
- 1
- Pages
- 4-31
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2137992445
- Cited by
- 474
- References
- 100
- FWCI
- 17.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Natural Sciences and Engineering Research Council of Canada
- Griffith Laboratories Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.